Navigation Links
ViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software
Date:2/23/2011

CLEVELAND, Feb. 23, 2011 /PRNewswire/ -- ViewRay™, Inc., a privately held medical device company, has received U.S. FDA marketing clearance for its radiotherapy treatment planning and delivery software. The software is a critical component of the company's new radiation therapy system, which combines simultaneous magnetic resonance imaging and radiotherapy delivery. Now in the late stages of development, the integrated ViewRay system is currently available only as a non–human use research system. The company is working to secure FDA clearance for commercial distribution of the system for clinical use.

"FDA clearance of our software represents a significant milestone in the development of the ViewRay system," said ViewRay President and CEO Gregory M. Ayers, MD, PhD. "In the past year ViewRay has achieved a string of notable successes, in funding and partnerships as well as product development. It's exciting to see such progress with a product we believe will offer an advancement in radiation therapy." The ViewRay system is being designed to provide continuous soft-tissue MRI during cancer treatment so that clinicians can see precisely where the radiation is being delivered.

ViewRay holds the exclusive worldwide license for its combination of MRI and radiotherapy technologies. The company recently secured $20 million in Series C financing intended to move the ViewRay system through the final development and regulatory processes, and toward the goal of commercialization and placement in major medical centers.

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is being designed to provide continuous soft-tissue imaging during treatment. The system is being developed so that clinicians will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. For more information, visit http://www.viewray.com.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.

ViewRay is a trademark of ViewRay, Inc.


'/>"/>
SOURCE ViewRay Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViewRay Secures Series C Financing
2. Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System
3. ViewRay Wins NorTech Innovation Award
4. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
5. Delcath Systems Receives Refusal to File Letter From FDA
6. Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
7. Sevocity, a Division of Conceptual MindWorks, Incs Sevocity Receives ONC-ATCB 2011/2012 Certification
8. Jardogs FollowMyHealth™ Universal Health Record Receives ONC-ATCB Certification
9. AirPal Receives Patent for Inflatable Patient Positioning Systems
10. Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark
11. TechPrecision Corporation Receives New $450,000 Medical Purchase Order
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... 2017 , ... An increase in wetter weather in the Northern California area ... that; a humdinger of an allergy season. A relief from drought conditions is most ... grass and weed pollen. , “Our patients have been reporting the typical allergy ...
(Date:6/25/2017)... ... ... is Men’s Health Month and the focus is on prostate cancer. Second only ... and the third most common cause of cancer related death today; lung cancer remains in ... diagnosed with prostate cancer during his lifetime. Those at highest risk are men ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and ... so that visits to the dentist fit into their patients’ busy lifestyles. Dental365 ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... ... June 23, 2017 , ... Yesterday, ... proposed healthcare bill to repeal and replace the Affordable Care Act (ACA). Like ... make significant cuts to Medicaid, a public health insurance program for low-income children, ...
Breaking Medicine News(10 mins):